SPEAKER

Ravi Vij, MD, MBA
Oncologist
Washington University School of Medicine –
Siteman Cancer Center

 

Ravi Vij, MD, MBA, is Professor of Medicine in the Division of Medical Oncology, Section of Bone Marrow Transplantation and Leukemia at Washington University in Saint Louis, Missouri. He received his medical degree from the University of Delhi, India, He completed a residency in medicine at Rush Presbyterian St Luke’s Medical Center in Chicago and fellowships in medical oncology/hematology and bone marrow transplantation/malignant hematology/stem cell biology at Washington University. He completed a healthcare MBA from George Washington University in Washington, DC.

He serves on numerous committees including the Cancer and Leukemia Group B (CALGB) Core Transplant, Myeloma, and Leukemia Committees; the Protocol Review Committee of the MMRC, Steering Committee of CoMMpass and PREABMBLE Myeloma Registries and the The Blood and Transplant Clinical Trials Network (BMT CTN) Myeloma Committee. Dr Vij’s honors include the Multiple Myeloma Research Foundation (MMRF) Innovator Award (2013) and the Multiple Myeloma Research Consortium (MMRC) Center of Excellence Award (2011) and the MMRF Collaborator Award (2017).

He is an author or coauthor of over 200 publications in journals, such as: Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation and others.  Dr Vij has also authored a book, Contemporary Management of Multiple Myeloma, as well as several book chapters including, Multiple Myeloma and Plasma Cell Dyscrasias in The Washington Manual of Oncology. He has served as a reviewer for journals including Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Leukemia and Lymphoma, Clinical Lymphoma and Myeloma, and Haematologica.

Dr Vij’s primary academic interests include the treatment of hematologic malignancies and hematopoietic stem cell transplantation. His research interests involve multiple myeloma and acute myeloid leukemia (AML)/myelodysplastic syndromes

Follow LLS